Resq Pharmaceuticals
Henderson, US · Founded 2019 · Delaware corporation
Founders & leadership
BE
BEN ESQUENamed on SEC filing
Reported raises · per SEC filings
Form D private placements$9.1M disclosed across 2 rounds · 2020–2021
▶$8.8MraisedJun 2021 · 52 investors · PharmaceuticalsRule 506(b)
▶$8.8MraisedJun 2021 · 52 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- BEN ESQUEExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $8.8M
- Proceeds to insiders
- $9.9M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$247KraisedApr 2020 · 2 investors · PharmaceuticalsRule 506(c)
▶$247KraisedApr 2020 · 2 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- John T. HyattPromoter
- Ben EsqueExecutive Officer
- Offering amount
- $2M
- Amount sold
- $247K
- Minimum investment
- $50K
- Proceeds to insiders
- $200K
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06c, 04.3
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Resq Pharmaceuticals raised?
- Resq Pharmaceuticals has disclosed $9.1M raised across 2 rounds.
- Where is Resq Pharmaceuticals headquartered?
- Resq Pharmaceuticals is headquartered in Henderson, US.